Drag

In-Out Licensing

At KLM Laboratories, we are committed to advancing healthcare through innovation and collaboration. We recognize the value of external partnerships and the importance of in-licensing to expand our product portfolio, access cutting-edge technologies, and enter new markets. If you have a product or technology that aligns with our mission and expertise, we invite you to explore in-licensing opportunities with us.

In-Licensing Opportunities

  • Pipeline Expansion: Collaborate on innovative drugs with KLM Labs—advancing therapies, preclinical to clinical stages, for global impact
  • Tech Advancements: Revolutionize drug development with KLM Labs. Explore breakthrough tech in-licensing for enhanced research and manufacturing
  • IP and Patents: KLM Labs actively licenses IP and patents in drug discovery. Discuss collaborations aligning with our strategic goals.
  • Market Expansion: Expand your product portfolio with KLM Labs. Seeking strategic partnerships for in-licensing marketed products in diverse therapeutic areas
  • Global/Regional Licensing: Collaborate with KLM Labs. Tailor licensing agreements for mutual benefits. Explore impactful healthcare partnerships now

Out-Licensing Opportunities

  • Out-License Your Innovations: Unlock the potential of your innovations! Explore out-licensing opportunities with us and bring your discoveries to the world.
  • Strategic Technology Partnerships: Collaborate with us in out-licensing breakthrough technologies. Let's build strategic partnerships for mutual success in advancing healthcare.
  • Monetize Your Intellectual Property: Maximize the value of your IP! Out-license patents and intellectual property with us and turn your innovations into impactful solutions.
  • Global Market Access: Expand globally through out-licensing agreements. Partner with us to leverage our market access and amplify the reach of your products.
  • Customized Regional Collaborations: Tailor your collaborations! Explore out-licensing regionally with us and customize partnerships for optimal market penetration and success.

Evaluation Criteria

KLM Laboratories evaluates in-licensing opportunities based on a set of rigorous criteria, which may include

  • Clinical Development Stage: We consider opportunities at various stages of development, from early-stage research to late-stage clinical trials.
  • Clinical Data: Strong clinical data supporting safety and efficacy are highly valued.
  • Intellectual Property: Robust intellectual property protection is essential for securing our investments.
  • Market Potential: We assess the market size, competitive landscape, and commercialization potential.
  • Alignment with Strategy: We prioritize opportunities that align with our strategic objectives and core competencies.

If you believe your product or technology fits our areas of interest and meets our evaluation criteria, we encourage you to reach out to us. Please contact our Licensing and Business Development team for inquiries, submissions, or to initiate discussions

The In-Out Licensing Process

Our in-out licensing process typically involves the following stages

  • Initial Inquiry: Submit your proposal or inquiry to our team.
  • Evaluation: Our experts will review your submission and assess its alignment with our criteria.
  • Due Diligence: If your proposal meets our initial criteria, we will conduct due diligence to further evaluate the opportunity.
  • Negotiation: We will engage in negotiations to structure a mutually beneficial agreement.
  • Agreement: Upon successful negotiations and approvals, we will formalize the in-licensing agreement.
  • Development and Commercialization: We collaborate closely to develop, manufacture, and commercialize the product or technology.

We value transparency, professionalism, and the potential for long-term partnerships. At KLM Laboratories, we believe that together, we can make a significant impact on improving healthcare outcomes. Thank you for considering KLM Laboratories as your in-licensing partner. We look forward to exploring innovative opportunities with you.